Leap Therapeutics
LPTX
LPTX
46 hedge funds and large institutions have $28.9M invested in Leap Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5.43% more ownership
Funds ownership: 33.08% → 38.51% (+5.4%)
5% more funds holding
Funds holding: 44 → 46 (+2)
Holders
46
Holding in Top 10
–
Calls
$43K
Puts
$16K
Top Buyers
| 1 | +$4.76M | |
| 2 | +$3.48M | |
| 3 | +$1.67M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$1.39M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$695K |
Top Sellers
| 1 | -$718K | |
| 2 | -$488K | |
| 3 | -$312K | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$105K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$98.9K |